Clinical Trials
61 trialsEfficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Ningbo No.2 Hospital
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Eunice Dube
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
Sun Yat-sen University
TRACER
University of Texas Southwestern Medical Center
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Mondelta
Hospices Civils de Lyon
MHALT
University of California, San Francisco
LHWAA
Thomas Jefferson University
HBV-Biomark
Assistance Publique - Hôpitaux de Paris
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Mayo Clinic
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Darul Sehat Hospital
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
Peking Union Medical College Hospital
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
National Taiwan University Hospital
Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients
Post Graduate Institute of Medical Education and Research, Chandigarh
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
M.D. Anderson Cancer Center
Effects of Antiviral Therapy on Patients With HBV-related HCC
First Affiliated Hospital Xi'an Jiaotong University
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
GEHEP-002
Hospital Universitario de Valme
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
Third Affiliated Hospital, Sun Yat-Sen University
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Beijing Ditan Hospital
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sun Yat-sen University
Tenofovir to Prevent HBV Reactivation
University Health Network, Toronto
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Beijing 302 Hospital
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Samsung Medical Center
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
OPTISCREEN-B
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Increasing Hepatitis B Screening Among Korean Church Attendees
University of California, Los Angeles
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
VDHCC
Third Affiliated Hospital, Sun Yat-Sen University
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital
TACEPVE
Eastern Hepatobiliary Surgery Hospital
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
Kyoto University Hospital
ROLFH
University of Arkansas
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Peking University
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
Universitaire Ziekenhuizen KU Leuven
HBV/HCC
Azienda Ospedaliera San Camillo Forlanini
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Genetic Analysis of Liver Cancer
Stanford University